Uterine Fibroids clinical trials at UCLA
2 in progress, 1 open to eligible people
open to eligible females ages 18-50
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Los Angeles, California and other locations
Sorry, in progress, not accepting new patients
This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids. In addition, data from this study is being used to satisfy the requirements of the United States Food and Drug Administration's 522 (post market surveillance) order.
Santa Monica, California and other locations